Joe Lundberg, senior meteorologist at Accuweather, joined Cheddar News to explain atmospheric rivers and dangerous weather slamming the state of California. "It's not very common for it to happen with this frequency," he noted.
Share:
More In Science
Maine's Lobster Boom Could Go Bust Amid Climate Change Pressures
Climate change that may have contributed to a lobster boom in Maine could soon lead to a bust. Chloe Aiello reports.
Good Morning America's Strahan Among Blue Origin Crew
Good Morning America co-host Michael Strahan will be among the crew on Blue Origin’s next flight to space.
Fighting Gas Prices, U.S. to Release 50 Million Barrels of Oil
President Joe Biden is ordering a record-setting 50 million barrels of oil released from America's strategic reserve to help bring down energy costs.
Need2Know: Waukesha Suspect, Black Friday Creep & Asteroid Mission
All the news you Need2Know for Tuesday, November 23, 2021.
U.S. Advisers Support Expanding COVID Boosters to All Adults
The U.S. is moving to open up COVID-19 booster shots to all adults, letting them choose another dose of either the Pfizer or Moderna vaccine.
U.S. Overdose Deaths Topped 100,000 in One Year, Officials Say
U.S. health officials say an estimated 100,000 Americans died of drug overdoses in one year. That's a total the nation has never seen.
Russia Rejects Accusations of Endangering ISS Astronauts
Russian officials on Tuesday rejected accusations that they endangered astronauts aboard the International Space Station by conducting a weapons test that created more than 1,500 pieces of space junk.
Austria Locks Down the Unvaccinated Amid a Surge of COVID-19
Austria has taken what its leader called the “dramatic” step of implementing a nationwide lockdown for unvaccinated people who haven’t recently had COVID-19.
Pfizer Says COVID-19 Pill Cut Hospital, Death Risk by 90%
Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.
